DOI:
10.1055/s-00035026
Applied Clinical Informatics
LinksClose Window
References
National Institute of Clinical Excellence (NICE).
Surveillance report 2018–Cardiovascular disease: risk assessment and reduction, including lipid modification.
NICE guideline CG181. 2014. Accessed May 15, 2022 at:
https://www.nice.org.uk/guidance/cg181/resources/surveillance-report-2018-cardiovascular-disease-risk-assessment-and-reduction-including-lipid-modification-2014-nice-guideline-cg181-4724759773/chapter/Surveillance-decision?tab=evidence
We do not assume any responsibility for the contents of the web pages of other providers.